Integrium, LLC to Attend RESI Conference, Boston

Tustin, CA – Integrium, LLC announced they will be attending the Redefining Early Stage Investments (RESI) Conference on September 13, 2016 in Boston, MA. Integrium has attended numerous RESI Conferences in the past and has been able to develop key relationships through workshops, panels, and group discussions.

Integrium, LLC would like to welcome Ying to the Clinical Data Management team with her role as Clinical Data Manager!

Ying focuses on following a healthy life schedule combined with Western and Eastern medicine. She enjoys great tasting food, except ones with strong bitter flavors!

Her favorite vacation spot is any place near water (but staying away from mosquitos) and has traveled to many places including Toronto, Korea, Thailand, Middle and Southwest China, California, Washington D.C., Philadelphia, Boston, and New York.

Booming Biosimilars

By Emily MacHale
July 5, 2016

The Biosimilar market is estimated to save the United States over $44 billion by 2024 when many branded biologics are coming off patent protection.

Slightly different from generics and biological reference products, biosimilars are complex in their manufacturing and data, leaving the FDA to confirm its’ safety and efficacy to pass regulations.

Marcum MicroCap Conference


WHEN: June 1-2, 2016

WHERE: Grand Hyatt, New York, NY


The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community.

RESI Conference – Houston, TX

RESI Conference
April 2016
Redefining Early
Stage Investments

WHEN: April 11, 2016

WHERE: Houston, TX


The RESI Conference series brings together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.

Jefferies 2016 Healthcare Conference – New York

WHEN: June 7-10, 2016


WHERE: New York, NY 



Following the success of last year’s event, with nearly 350 participating companies and over 2,500 attendees, the conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors.